Triastek Closes US$ 50 Million Series B Financing, Co-led by Matrix Partners China and CPE

Retrieved on: 2021-06-24 11:37:30

Tags for this article:

Articles

Health sciences

Life Sciences

Pharmaceutical industry

Pharmaceuticals policy

Emerging technologies

Industrial design

Industrial processes

Pharmaceutical industry in China

Click the tags to see associated articles and topics

Triastek Closes US$ 50 Million Series B Financing, Co-led by Matrix Partners China and CPE. View article details on hiswai:

Excerpt

Matrix Partners China partner Dr. Eric Yu added, "Triastek's breakthrough 3D printing pharmaceutical technology platform can create almost all types of ...

Article found on: www.prnewswire.com

View Original Article